Genome-wide exome sequencing studies have revealed a plethora of mutations and epigenetic alterations that are involved in genome maintenance along with the Wnt, MEK–ERK, PI3K, TGF-β, and p53 pathways to be the primary mediators of CRC development [9, 43]. The gene discussed is MAP2K7; the disease is colorectal carcinoma.